SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EntreMed (ENMD)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anthony@Pacific who wrote (1567)2/11/1999 10:13:00 PM
From: Dave Gore  Read Replies (1) of 2135
 
Wrong! They never said THAT in the release, either..Anthony, you are losing respect fast ....geese, man....LOL

AGAIN.... from the BMY NEWS RELEASE:
"Under their revised agreement.... Bristol-Myers
Squibb has the option to "reassume" development
and marketing once proof that the protein meets its
criteria for clinical trials becomes clear."

Sounds to me that BMY wanted a revised agreement that keeps all their options open, huh?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News